One of the major goals of tumor immunology is effective immunization of the cancer patient against his own tumor. Several approaches to immunotherapy that have received or are currently receiving clinical trials are outlined, with emphasis on the theoretical background and the general outlook for each approach. Some optimum requirements for immunotherapy are listed, as are the known escape mechanisms and the newer therapeutic approaches undergoing laboratory evaluation that may circumvent these escape mechanisms.
No takes yet. Share an insight, caveat, or question.
McKhann et al. (1974) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: